BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7762389)

  • 1. Four-week use of oxymetazoline nasal spray (Nezeril) once daily at night induces rebound swelling and nasal hyperreactivity.
    Graf P; Hallén H; Juto JE
    Acta Otolaryngol; 1995 Jan; 115(1):71-5. PubMed ID: 7762389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers.
    Graf P; Hallén H; Juto JE
    Clin Exp Allergy; 1995 May; 25(5):395-400. PubMed ID: 7553241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays.
    Graf P; Hallén H
    Laryngoscope; 1996 May; 106(5 Pt 1):605-9. PubMed ID: 8628089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decongestion effect and rebound swelling of the nasal mucosa during 4-week use of oxymetazoline.
    Graf P; Juto JE
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(3):157-60. PubMed ID: 7515487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis.
    Graf P; Enerdal J; Hallén H
    Arch Otolaryngol Head Neck Surg; 1999 Oct; 125(10):1128-32. PubMed ID: 10522506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between objective nasal mucosal swelling and estimated stuffiness during long-term use of vasoconstrictors.
    Graf P; Juto JE
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(6):334-9. PubMed ID: 7530821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzalkonium chloride in nasal decongestive sprays has a long-lasting adverse effect on the nasal mucosa of healthy volunteers.
    Hallén H; Graf P
    Clin Exp Allergy; 1995 May; 25(5):401-5. PubMed ID: 7553242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine sensitivity in the nasal mucosa during four-week use of oxymetazoline.
    Graf P; Juto JE
    Rhinology; 1994 Sep; 32(3):123-6. PubMed ID: 7839081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One year follow-up of patients with rhinitis medicamentosa after vasoconstrictor withdrawal.
    Graf PM; Hallén H
    Am J Rhinol; 1997; 11(1):67-72. PubMed ID: 9065350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluticasone propionate nasal spray is more effective and has a faster onset of action than placebo in treatment of rhinitis medicamentosa.
    Hallén H; Enerdal J; Graf P
    Clin Exp Allergy; 1997 May; 27(5):552-8. PubMed ID: 9179430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of nasal response following different treatment regimes of oxymetazoline with reference to rebound congestion.
    Morris S; Eccles R; Martez SJ; Riker DK; Witek TJ
    Am J Rhinol; 1997; 11(2):109-15. PubMed ID: 9129752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling.
    Graf P; Juto JE
    Rhinology; 1995 Mar; 33(1):14-7. PubMed ID: 7540314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis.
    Meltzer EO; Bernstein DI; Prenner BM; Berger WE; Shekar T; Teper AA
    Am J Rhinol Allergy; 2013; 27(2):102-8. PubMed ID: 23562197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the effect of nasal steroid sprays in perennial allergic rhinitis patients with rhinitis medicamentosa.
    Ferguson BJ; Paramaesvaran S; Rubinstein E
    Otolaryngol Head Neck Surg; 2001 Sep; 125(3):253-60. PubMed ID: 11555762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of mometasone furoate aqueous nasal spray in the treatment of rhinitis medicamentosa: an experimental study.
    Tas A; Yagiz R; Yalcin O; Uzun C; Huseyinova G; Adali MK; Karasalihoglu AR
    Otolaryngol Head Neck Surg; 2005 Apr; 132(4):608-12. PubMed ID: 15806055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis.
    Baroody FM; Brown D; Gavanescu L; DeTineo M; Naclerio RM
    J Allergy Clin Immunol; 2011 Apr; 127(4):927-34. PubMed ID: 21377716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of oxymetazoline plus intranasal steroid in the treatment of chronic rhinitis: A randomised controlled trial.
    Thongngarm T; Assanasen P; Pradubpongsa P; Tantilipikorn P
    Asian Pac J Allergy Immunol; 2016 Mar; 34(1):30-7. PubMed ID: 26994623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.